What the cancer tools show for London Vivian Mak National Cancer Intelligence Network London Public Health Knowledge and Intelligence Network meeting Wednesday 28 January 2015

Background | London | Signpost 2

3 What we know nationally Source: National Audit Office Progress in improving cancer services and outcomes in England

4 What are the drivers? Breast and cervical cancer screening coverage 2 Cancer diagnosis via emergency routes 3 Cancer diagnosis at Stage 1 and 2 2,3 Record of stage at diagnosis for all cancers and for lung cancers 3 1-year and 5-year survival for breast, lung and bowel cancer (combined) 1,3 1-year and 5-year survival for all cancers (combined) 1,3 5 –year survival for all cancers in children 1 Under-75 mortality rate 1,2,3, breast cancer mortality 3

5 Source: Public Health Outcomes Framework, Jan 2015http:// Islington

6 Source: Public Health Outcomes Framework, Jan 2015http:// Kensington and Chelsea

7 National Awareness and Early Diagnosis Initiative (NAEDI) 2007 Source: Cancer Commissioning Toolkit, Jan 2015https:// 10.5%

8 Source: Cascade Jan 2015https://nww.cancerstats.encore.nhs.uk/users/sign_in Cancer incidence in London, 2012 Age-standardised incidence rates per 100,000 European Standard Population

9 Source: Cascade Jan 2015https://nww.cancerstats.encore.nhs.uk/users/sign_in Cancer incidence in London, , males Age-standardised incidence rates per 100,000 European Standard Population

10 Source: Cascade Jan 2015https://nww.cancerstats.encore.nhs.uk/users/sign_in Cancer incidence in London, , males Age-standardised incidence rates per 100,000 European Standard Population Prostate Lung Stomach

11 Source: Cascade Jan 2015https://nww.cancerstats.encore.nhs.uk/users/sign_in Cancer incidence in London, , females Age-standardised incidence rates per 100,000 European Standard Population

12 Source: Cascade Jan 2015https://nww.cancerstats.encore.nhs.uk/users/sign_in Cancer incidence in London, , females Age-standardised incidence rates per 100,000 European Standard Population Breast Cervix in-situ Uterus

13 Source: Public Health Outcomes Framework, Jan 2015http:// % of invasive malignancies of breast, prostate, colorectal, lung, bladder, kidney, ovary and uterus, non-Hodgkin lymphomas, and melanomas of skin, diagnosed at stage 1 or 2 (experimental) England London

14 Source: Cancer Commissioning Toolkit, Jan 2015https:// England London % 2012 lung cancers diagnosed at stage 1,2,3 & 4, London (experimental)

One-year survival index (%) for all cancers combined in London and England, 2012, adults aged years 15 Source: Office for National Statistics and London School of Hygiene and Tropical Medicine Jan 2015 “Geographic inequalities in the one-year survival index in London are only slightly narrower than those observed for the whole of England” Note: Highlighted figures indicate where London survival is significantly better than survival in England which is determined by whether the confidence intervals around the two survival estimates overlap.

16 Source: Office for National Statistics and London School of Hygiene and Tropical Medicine Jan 2015 One-year survival index (%) for all cancers combined in London and England, , adults aged years 64% 72.4%

17 One-year survival index (%) for breast, lung & bowel combined in London and England, , adults aged years Source: Office for National Statistics and London School of Hygiene and Tropical Medicine Jan % 71.3%

18 Source: Cascade Jan 2015https://nww.cancerstats.encore.nhs.uk/users/sign_in Cancer mortality in London, 2012 Age-standardised mortality rates per 100,000 European Standard Population

19 Source: Cascade Jan 2015https://nww.cancerstats.encore.nhs.uk/users/sign_in Cancer mortality in London, , males Age-standardised mortality rates per 100,000 European Standard Population Lung Prostate Colorectal

20 Source: Cascade Jan 2015https://nww.cancerstats.encore.nhs.uk/users/sign_in Cancer mortality in London, , females Age-standardised mortality rates per 100,000 European Standard Population Breast Colorectal Lung

21 Stakeholders in London London Cancer Commissioning Board London Health Commission 31 CCGs, 33 LAs London SCN London Cancer (incl West Essex) and London Cancer Alliance 27 NHS Trusts.ac.uk

22 Source:

23 cancer Source:

24 Thank you